CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2, beta | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CAND1 | Cullin-associated and neddylation-dissociated 1 | Plasma proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN14 | Calpain 14 | Enzymes
| | | | | Tissue enriched |
CAPRIN2 | Caprin family member 2 | Mitochondrial proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted membrane proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CASC4 | Cancer susceptibility candidate 4 | | | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
CCDC104 | Coiled-coil domain containing 104 | | | | | | Expressed in all |
CCDC132 | Coiled-coil domain containing 132 | | | | | | Expressed in all |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCNC | Cyclin C | | | | | | Expressed in all |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD47 | CD47 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDAN1 | Codanin 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDC14B | Cell division cycle 14B | Enzymes Predicted membrane proteins
| | | | | Mixed |
CDC27 | Cell division cycle 27 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK14 | Cyclin-dependent kinase 14 | Enzymes
| | | | | Expressed in all |
CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CENPI | Centromere protein I | | | | | | Mixed |
CEP170 | Centrosomal protein 170kDa | Predicted membrane proteins
| | | | | Expressed in all |
CEP89 | Centrosomal protein 89kDa | Disease related genes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
CERS2 | Ceramide synthase 2 | Predicted membrane proteins
| | | | | Expressed in all |
CERS6 | Ceramide synthase 6 | Predicted membrane proteins
| | | | | Expressed in all |
CFLAR | CASP8 and FADD-like apoptosis regulator | Cancer-related genes Enzymes
| | | | | Expressed in all |
CGRRF1 | Cell growth regulator with ring finger domain 1 | Predicted membrane proteins
| | | | | Expressed in all |
CHCHD3 | Coiled-coil-helix-coiled-coil-helix domain containing 3 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |